CCP
ELV icon

Cyrus Capital Partners’s Elevance Health ELV Stock Holding History

Cyrus Capital Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,000
Closed -$240K – 38
2019
Q3 		$240K Buy
+1,000
New +$274K 0.03% 16

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return

Cyrus Capital Partners's ELV Position: Q4 2019 in Review

Cyrus Capital Partners sold out of Elevance Health (ELV) in Q4 2019, closing a stake of 1,000 shares — an estimated $240K sold.

Cyrus Capital Partners first reported a position in ELV in Q3 2019 and held it in 1 quarter. The position peaked at $240K in Q3 2019. 1,110 funds tracked by Wall St. Rank hold ELV as of Q4 2019.

  • Cyrus Capital Partners reported no remaining Elevance Health position as of Q4 2019 after selling out during the quarter.
  • Cyrus Capital Partners sold 1,000 Elevance Health shares in Q4 2019, an estimated $240K.
  • Cyrus Capital Partners first reported a position in Elevance Health in Q3 2019 and held it in 1 quarter.
  • Cyrus Capital Partners's Elevance Health position peaked at $240K in Q3 2019.
  • 1,110 funds tracked by Wall St. Rank held Elevance Health as of Q4 2019.

Based on Cyrus Capital Partners's 13F filing for Q4 2019, filed 14 Feb 2020.